相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content
Sigrun Chrubasik-Hausmann et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
The Regional-Specific Relative and Absolute Expression of Gut Transporters in Adult Caucasians: A Meta-Analysis
Matthew D. Harwood et al.
DRUG METABOLISM AND DISPOSITION (2019)
Transcriptional and Post-Transcriptional Regulation of Duodenal P-Glycoprotein and MRP2 in Healthy Human Subjects after Chronic Treatment with Rifampin and Carbamazepine
Susanne Brueck et al.
MOLECULAR PHARMACEUTICS (2019)
Sex-, feeding-, and circadian time-dependency of P-glycoprotein expression and activity - implications for mechanistic pharmacokinetics modeling
Alper Okyar et al.
SCIENTIFIC REPORTS (2019)
Protein Abundance of Clinically Relevant Drug Transporters in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens
Marek Drozdzik et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
The prominent impairment of liver/intestinal cytochrome P450 and intestinal drug transporters in sepsis-induced acute kidney injury over acute and chronic renal ischemia, a mouse model comparison
Warumphon Sukkummee et al.
RENAL FAILURE (2019)
Optimization of a drug transporter probe cocktail: potential screening tool for transporter-mediated drug-drug interactions
Peter Stopfer et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium
Raymond Evers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
An animal's sex influences the effects of the excipient PEG 400 on the intestinal P-gp protein and mRNA levels, which has implications for oral drug absorption
Yang Mai et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Sex differences in the gastrointestinal tract of rats and the implications for oral drug delivery
Francisco Afonso-Pereira et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review
Meng Chen et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2018)
LC-MS/MS method for the simultaneous quantification of intestinal CYP and UGT activity
Diana Busch et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction
Hideki Fujii et al.
TOXINS (2018)
Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs
Xingwang Zhang et al.
PHARMACEUTICS (2018)
Nonionic surfactants increase digoxin absorption in Caco-2 and MDCKII MDR1 cells: Impact on P-glycoprotein inhibition, barrier function, and repeated cellular exposure
Ahmed A. Abdulhussein Al-Ali et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Inhibitory Effects of Commonly Used Excipients on P-Glycoprotein in Vitro
Rohan Gurjar et al.
MOLECULAR PHARMACEUTICS (2018)
The importance of the polymorphisms of the ABCB1 gene in disease susceptibility, behavior and response to treatment in inflammatory bowel disease: A literature review
Paweł Petryszyn et al.
Advances in Clinical and Experimental Medicine (2018)
Validation of a Microdose Probe Drug Cocktail for Clinical Drug Interaction Assessments for Drug Transporters and CYP3A
T. Prueksaritanont et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Absorption sites of orally administered drugs in the small intestine
Teruo Murakami
EXPERT OPINION ON DRUG DISCOVERY (2017)
Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin
I. Gouin-Thibault et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
Saikat Dewanjee et al.
MOLECULES (2017)
Systems Chronotherapeutics
Annabelle Ballesta et al.
PHARMACOLOGICAL REVIEWS (2017)
P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers
Elke Cario
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide
Sjoerd de Hoogd et al.
CLINICAL PHARMACOKINETICS (2017)
Improved oral bioavailability and therapeutic efficacy of dabigatran etexilate via Soluplus-TPGS binary mixed micelles system
Mei Hu et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2017)
Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and Rosuvastatin
P. Stopfer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia
B. A. Adeagbo et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2016)
SUMOylation of pregnane X receptor suppresses rifampicin-induced CYP3A4 and P-gp expression and activity in LS174T cells
Huasen Tan et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2016)
Oral Morphine Pharmacokinetic in Obesity: The Role of P-Glycoprotein, MRP2, MRP3, UGT2B7, and CYP3A4 Jejunal Contents and Obesity-Associated Biomarkers
Celia Lloret-Linares et al.
MOLECULAR PHARMACEUTICS (2016)
A solid self-nanoemulsifying system of the BCS class IIb drug dabigatran etexilate to improve oral bioavailability
Fujuan Chai et al.
NANOMEDICINE (2016)
Effects of polyethylene glycols on intestinal efflux pump expression and activity in Caco-2 cells
Darya Hodaei et al.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Interaction of Drug or Food with Drug Transporters in Intestine and Liver
Takeo Nakanishi et al.
CURRENT DRUG METABOLISM (2015)
Decreased functional activity of multidrug resistance protein in primary colorectal cancer
Micsik Tamas et al.
Diagnostic Pathology (2015)
Drug gastrointestinal absorption in rat: Strain and gender differences
Davinia Oltra-Noguera et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Increased intestinal P-glycoprotein expression and activity with progression of diabetes and its modulation by epigallocatechin-3-gallate: Evidence from pharmacokinetic studies
Ranjeet Prasad Dash et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Excipient pharmacokinetics and profiling
Thorsteinn Loftsson
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Application of an LC-MS/MS method for the simultaneous quantification of human intestinal transporter proteins absolute abundance using a QconCAT technique
M. D. Harwood et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical SettingProposal of a Four Component Transporter Cocktail
Thomas Ebner et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Changes of Absorptive and Secretory Transporting System of (1 -> 3) beta-D-glucan Based on Efflux Transporter in Indomethacin-induced Rat
Aiko Iida et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2015)
Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients
Ola Sharaki et al.
MOLECULAR BIOLOGY REPORTS (2015)
High ABCC2 and Low ABCG2 Gene Expression Are Early Events in the Colorectal Adenoma-Carcinoma Sequence
Vibeke Andersen et al.
PLOS ONE (2015)
Circadian Modulation in the Intestinal Absorption of P-Glycoprotein Substrates in Monkeys
Masaru Iwasaki et al.
MOLECULAR PHARMACOLOGY (2015)
Review on immunosuppression in liver transplantation
Maryam Moini et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Physiologically based pharmacokinetic modelling and in vivo [I]/Ki accurately predict P-glycoprotein-mediated drug-drug interactions with dabigatran etexilate
Yuansheng Zhao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Mechanisms of Lower Maintenance Dose of Tacrolimus in Obese Patients
Kazuki Sawamato et al.
DRUG METABOLISM AND PHARMACOKINETICS (2014)
Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics
C. Groeer et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Distinct Alterations in ATP-Binding Cassette Transporter Expression in Liver, Kidney, Small Intestine, and Brain in Adjuvant-Induced Arthritic Rats
Atsushi Kawase et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Downregulation of CYP3A and P-Glycoprotein in the Secondary Inflammatory Response of Mice With Dextran Sulfate Sodium Induced Colitis and Its Contribution to Cyclosporine A Blood Concentrations
Shoji Kawauchi et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2014)
Intestinal P-glycoprotein Expression is Multimodally Regulated by Intestinal Ischemia-Reperfusion
Yusuke Terada et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2014)
Protein Abundance of Clinically Relevant Multidrug Transporters along the Entire Length of the Human Intestine
Marek Drozdzik et al.
MOLECULAR PHARMACEUTICS (2014)
Personalized Tacrolimus Dose Requirement by CYP3A5 but Not ABCB1 or ACE Genotyping in Both Recipient and Donor after Pediatric Liver Transplantation
Yi-kuan Chen et al.
PLOS ONE (2014)
Effects of Elevated Tacrolimus Trough Levels in Association With Infectious Enteritis on Graft Function in Renal Transplant Recipients
A. Nakamura et al.
TRANSPLANTATION PROCEEDINGS (2014)
Inflammatory bowel disease: Pathogenesis
Yi-Zhen Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Mass Spectrometry-Based Targeted Proteomics as a Tool to Elucidate the Expression and Function of Intestinal Drug Transporters
Stefan Oswald et al.
AAPS JOURNAL (2013)
Diurnal cortisol rhythm as a predictor of lung cancer survival
Sandra E. Sephton et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Impact of OATP1B1, MDR1, and CYP3A4 Expression in Liver and Intestine on Interpatient Pharmacokinetic Variability of Atorvastatin in Obese Subjects
M. Ulvestad et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
The Role of Inter-segmental Differences in P-glycoprotein Expression and Activity along the Rat Small Intestine in Causing the Double-peak Phenomenon of Substrate Plasma Concentration
Sho Wada et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
Expression of Membrane Drug Efflux Transporters in the Sigmoid Colon of HIV-Infected and Uninfected Men
Maria Fabiana De Rosa et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
LC-MS/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins
C. Groeer et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)
Low ABCB1 Gene Expression Is an Early Event in Colorectal Carcinogenesis
Vibeke Andersen et al.
PLOS ONE (2013)
Application of Receiver Operating Characteristic Analysis to Refine the Prediction of Potential Digoxin Drug Interactions
Harma Ellens et al.
DRUG METABOLISM AND DISPOSITION (2013)
Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin
Sebastian Haertter et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Circadian Variations in Exsorptive Transport: In Situ Intestinal Perfusion Data and In Vivo Relevance
Alper Okyar et al.
CHRONOBIOLOGY INTERNATIONAL (2012)
Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health
Karin Dilger et al.
JOURNAL OF HEPATOLOGY (2012)
Circadian Rhythm Disruption in Cancer Biology
Christos Savvidis et al.
MOLECULAR MEDICINE (2012)
Association Between Lamotrigine Concentrations and ABCB1 Polymorphisms in Patients With Epilepsy
Mila Lovric et al.
THERAPEUTIC DRUG MONITORING (2012)
Effect of genistein on the activities of cytochrome P450 3A and P-glycoprotein in Chinese healthy participants
C. -Q. Xiao et al.
XENOBIOTICA (2012)
Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice
Seema Saksena et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Circadian rhythm of adrenal glucocorticoid: Its regulation and clinical implications
Sooyoung Chung et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
The role of P-glycoprotein and breast cancer resistance protein (BCRP) in bacterial attachment to human gastrointestinal cells
Andrew Crowe
JOURNAL OF CROHNS & COLITIS (2011)
Altered intestinal P-glycoprotein expression levels in a monosodium glutamate-induced obese mouse model
Ayaka Nawa et al.
LIFE SCIENCES (2011)
Chronotherapeutic strategy: Rhythm monitoring, manipulation and disruption
Shigehiro Ohdo
ADVANCED DRUG DELIVERY REVIEWS (2010)
Effects of Dietary Ingredients on Function and Expression of P-Glycoprotein in Human Intestinal Epithelial Cells
Takashi Okura et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2010)
Effect of Obesity on the Pharmacokinetics of Drugs in Humans
Michael J. Hanley et al.
CLINICAL PHARMACOKINETICS (2010)
The Impact of Thyroid Disease on the Regulation, Expression, and Function of ABCB1 (MDR1/P-Glycoprotein) and Consequences for the Disposition of Digoxin
O. Burk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Modulation of the Activity of ABC Transporters (P-Glycoprotein, MRP2, BCRP) by Flavonoids and Drug Response
Ana I. Alvarez et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Species Difference in the Effect of Grapefruit Juice on Intestinal Absorption of Talinolol between Human and Rat
Yoshiyuki Shirasaka et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Effect of intestinal ischaemia/reperfusion on P-glycoprotein-mediated ileal excretion of rhodamine 123 in the rat
Mikio Tomita et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy
Sharon Chan et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2010)
Effects of Ginkgo biloba Extract Ingestion on the Pharmacokinetics of Talinolol in Healthy Chinese Volunteers
Lan Fan et al.
ANNALS OF PHARMACOTHERAPY (2009)
Effects of Obesity Induced by High-fat Diet on the Pharmacokinetics of Nelfinavir, A HIV Protease Inhibitor, in Laboratory Rats
Nobuyuki Sugioka et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2009)
Effects of Oral Epigallocatechin Gallate on the Oral Pharmacokinetics of Verapamil in Rats
Joong-Hwa Chung et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2009)
Modified-Release Hydrocortisone to Provide Circadian Cortisol Profiles
Miguel Debono et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Decreased Oral Absorption of Cyclosporine A after Liver Ischemia-Reperfusion Injury in Rats: The Contribution of CYP3A and P-Glycoprotein to the First-Pass Metabolism in Intestinal Epithelial Cells
Kenji Ikemura et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Grapefruit Juice and its Constituents Augment Colchicine Intestinal Absorption: Potential Hazardous Interaction and the Role of P-Glycoprotein
Arik Dahan et al.
PHARMACEUTICAL RESEARCH (2009)
Decreased sigmoidal ABCB1 (P-glycoprotein) expression in ulcerative colitis is associated with disease activity
Mike Ufer et al.
PHARMACOGENOMICS (2009)
Breast Cancer Resistance Protein and P-Glycoprotein Expression in Patients with Newly Diagnosed and Therapy-Refractory Ulcerative Colitis Compared with Healthy Controls
Heike Gutmann et al.
DIGESTION (2008)
Assessment of Ileal Epithelial P-Glycoprotein Dysfunction Induced by Ischemia/Reperfusion using in vivo Animal Model
Mikio Tomita et al.
DRUG METABOLISM AND PHARMACOKINETICS (2008)
Intestinal efflux transporters and drug absorption
Teruo Murakami et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats
Whocely Victor De Castro et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)
Alteration of Mrp2 and P-gp expression, including expression in remote organs, after intestinal ischemia-reperfusion
Jiro Ogura et al.
LIFE SCIENCES (2008)
Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients
Masahide Fukudo et al.
PHARMACOGENETICS AND GENOMICS (2008)
Induction of metabolism and transport in human intestine: Validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro
Esther G. Van De Kerkhof et al.
DRUG METABOLISM AND DISPOSITION (2008)
The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans
Stefan Blech et al.
DRUG METABOLISM AND DISPOSITION (2008)
Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels
Hans Blokzijl et al.
INFLAMMATORY BOWEL DISEASES (2007)
Circadian and time-dependent variability in tacrolimus pharmacokinetics
Sung-In Park et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2007)
Expression of cytochromes P450 3A and P-glycoprotein in human large intestine in paired tumour and normal samples
Roberto Canaparo et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
Down-regulation of intestinal drug transporters in chronic renal failure in rats
Judith Naud et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Intestinal drug transporter expression and the impact of grapefruit juice in humans
H. Glaeser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Efflux transporters in ulcerative colitis:: Decreased expression of BCRP (ABCG2) and Pgp (ABCB1)
Gunilla Englund et al.
INFLAMMATORY BOWEL DISEASES (2007)
Decreased intestinal CYP3A and p-glycoprotein activities in rats with adjuvant arthritis
Satoshi Uno et al.
DRUG METABOLISM AND PHARMACOKINETICS (2007)
Decreased PXR and CAR inhibit transporter and CYP mRNA Levels in the liver and intestine of mice with collagen-induced arthritis
A. Kawase et al.
XENOBIOTICA (2007)
Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans
Marija Tubic et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats
C. Y. Yang et al.
FOOD AND CHEMICAL TOXICOLOGY (2006)
Circadian pharmacokinetics of mycophenolic acid and implication of genetic polymorphisms for early clinical events in renal transplant recipients
Shigeru Satoh et al.
TRANSPLANTATION (2006)
Impact of inflammation on the duodenal mRNA expression of CYP3A and P-glycoprotein in children with Crohn's disease
May Fakhoury et al.
INFLAMMATORY BOWEL DISEASES (2006)
Changes in pharmacokinetics of anti-HIV protease inhibitors during pregnancy: The role of CYP3A and P-glycoprotein
AA Mathias et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Chronopharmacokinetics of ciclosporin and tacrolimus
Massimo Baraldo et al.
CLINICAL PHARMACOKINETICS (2006)
Effects of renal failure on drug transport and metabolism
H Sun et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Expression and function of efflux drug transporters in the intestine
M Takano et al.
PHARMACOLOGY & THERAPEUTICS (2006)
A higher dose requirement of tacrolimus in active Crohn's disease may be related to a high intestinal P-glycoprotein content
AL Buchman et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
No gender-associated differences of cyclosporine pharmacokinetics in stable renal transplant patients treated with diltiazem
CA Aros et al.
TRANSPLANTATION PROCEEDINGS (2005)
Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression
B Chowbay et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Cytochrome p450 3A4 and p-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea
W Lemahieu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen
W Weitschies et al.
PHARMACEUTICAL RESEARCH (2005)
Pharmacokinetic differences between morning and evening administration of cyclosporine and tacrolimus therapy
T Iwahori et al.
TRANSPLANTATION PROCEEDINGS (2005)
Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line
R Tian et al.
DRUG METABOLISM AND DISPOSITION (2005)
Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression?
MF Paine et al.
DRUG METABOLISM AND DISPOSITION (2005)
Transient up-regulation of P-glycoprotein reduces tacrolimus absorption after ischemia-reperfusion injury in rat ileum
T Omae et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system
CY Wu et al.
PHARMACEUTICAL RESEARCH (2005)
Tacrolimus therapy according to mucosal MDR1 levels in small-bowel transplant recipients
S Masuda et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2
CG Dietrich et al.
GASTROENTEROLOGY (2004)
CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus
WPD Lemahieu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Increased tacrolimus trough levels in association with severe diarrhea, A case report
T Asano et al.
TRANSPLANTATION PROCEEDINGS (2004)
Alterations of CYP3A4 and P-glycoprotein activity in vivo with time in renal graft recipients
WPD Lemahieu et al.
KIDNEY INTERNATIONAL (2004)
Loss of detoxification in inflammatory bowel disease: Dysregulation of pregnane X receptor target genes
T Langmann et al.
GASTROENTEROLOGY (2004)
Drug interactions with st John's Wort - Mechanisms and clinical implications
M Mannel
DRUG SAFETY (2004)
Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients
N Tsuchiya et al.
TRANSPLANTATION (2004)
P-glycoprotein increases from proximal to distal regions of human small intestine
S Mouly et al.
PHARMACEUTICAL RESEARCH (2003)
Enhanced expression of enterocyte P-glycoprotein depresses cyclosporine bioavailability in a recipient of living donor liver transplantation
S Masuda et al.
LIVER TRANSPLANTATION (2003)
Chronopharmacokinetics of tacrolimus in kidney transplant recipients: Occurrence of acute rejection
H Tada et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities
N Morita et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Differential effect of acute hepatic failure on in vivo and in vitro P-glycoprotein functions in the intestine
R Yumoto et al.
PHARMACEUTICAL RESEARCH (2003)
Digoxin pharmacokinetics and MDR1 genetic polymorphisms
C Verstuyft et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Altered expression and function of P-glycoprotein in dextran sodium sulfate-induced colitis in mice
H Iizasa et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers
ED Hugger et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates
R Tian et al.
PHARMACEUTICAL RESEARCH (2002)
Rifampin and Rifabutin drug interactions - An update
CK Finch et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols
J Jodoin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2002)
Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion
C Veau et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
Expression and function of P-glycoprotein in rats with carbon tetrachloride-induced acute hepatic failure
ZH Huang et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2001)
Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation
T Hashida et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
D Dürr et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure
ZH Huang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Relevance for chronopharmacology in practical medicine
B Lemmer
SEMINARS IN PERINATOLOGY (2000)
Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient
S Masuda et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy
RJ Farrell et al.
GASTROENTEROLOGY (2000)
Factors that affect absorption behavior of cyclosporin A in gentamicin-induced acute renal failure in rats
N Shibata et al.
RENAL FAILURE (2000)
分享论文
